Yuanyuan Chen

3.0k citations
125 papers · 2.1k indexed · 1 hit paper · h-index 25

Yuanyuan Chen

117 papers receiving 2.1k citations

Hit Papers

Long non-coding RNAs: From disease code to drug role3602020202620222024100200300

Peers

Yuanyuan Chen
Comparison fields: 5 of 143
  • Cancer Research 768
  • Molecular Biology 1.4k
  • Algebra and Number Theory 47
  • Immunology 150
  • Oncology 193
Replace David P. Lovell with:
David P. Lovell United Kingdom
Yingying Gao China
Sim Namkoong South Korea
Carmen Bedia Spain
Ru Wang China
Cheng Cheng China
Yan Pan China
Chengfu Yuan China
Bo Pang China
Elza Tiemi Sakamoto‐Hojo Brazil
Yuanyuan Chen relative to David P. Lovell United Kingdom David P. Lovell's profile →
Citations per field
00.5×9.6×
David P. Lovell · 1×
Citations per year

Countries citing papers authored by Yuanyuan Chen

Since Specialization
Citations

This map shows the geographic impact of Yuanyuan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanyuan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanyuan Chen more than expected).

Fields of papers citing papers by Yuanyuan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanyuan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanyuan Chen. The network helps show where Yuanyuan Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Yuanyuan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yuanyuan Chen Line = papers co-authored together Yuanyuan Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20256
2 20251
3 20251
4 20244
5 202418
6 202419
7 202310
8 202311
9 20224
10 20223
11 20221
12 202129
13 202129
14 202185
15 202118
16 20217
17 20205
18 201830
19 201854
20 20121

About Yuanyuan Chen

Yuanyuan Chen is a scholar working on Algebra and Number Theory, Cancer Research and Geometry and Topology, having authored 125 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (12 papers), Algebraic structures and combinatorial models (12 papers), Advanced Topics in Algebra (12 papers), Gene expression and cancer classification (11 papers), Bioinformatics and Genomic Networks (10 papers), MicroRNA in disease regulation (8 papers) and Machine Learning in Bioinformatics (7 papers). The work is most often cited by research in Cancer Research (768 citations), Molecular Biology (1.4k citations) and Algebra and Number Theory (47 citations). Yuanyuan Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Sen Zhang, Zhaojun Li, Xiaoguang Chen, Liangyun Zhang, Cong Pian, A. Corina Vlot, Maaria Rosenkranz, Mingmin Xu, Zhi Chen and Jin Zhang. Their work appears in journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026